CONTACT US | Phone: 1-800-537-2790
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG
  • COMPANY
    • OVERVIEW
    • QUALITY
    • CAREERS
  • PRODUCTS
    • RENUVION®
    • J-PLASMA®
    • PATENTS
    • SYMBOL GLOSSARY
    • Electronic IFU Portal
    • Electronic IFU Portal
  • INVESTOR RELATIONS
  • BLOG

Case Study

Home » Case Study
By apyxmedical
In 2020 Shareholder News, Case Study, J-Plasma, Renuvion
Posted November 23, 2020

APYX MEDICAL CORPORATION ANNOUNCES APPROVAL FROM FDA TO BEGIN PHASE II OF U.S. IDE STUDY

READ MORE
By apyxmedical
In 2020 Shareholder News, Case Study, J-Plasma, Renuvion
Posted November 9, 2020

APYX MEDICAL CORPORATION ANNOUNCES UPDATES ON U.S. IDE CLINICAL STUDIES

READ MORE

© Copyright 2022 Apyx Medical. All rights reserved. Renuvion®, J-Plasma® and Reshaping What's Possible® are registered trademarks of Apyx Medical Corporation. Bovie® is a registered trademark of Symmetry Surgical. Energy Elevating Lives℠ is a service mark of Apyx Medical Corporation. Apyx™ is a trademark of Apyx Medical Corporation.

Contact Us | Privacy Policy | Terms of Use | Disclaimer

Top